Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Peanut Oral Immunotherapy (OIT) confers long-term tolerance mediated by decreased T-helper Type 2 (TH2) cytokines and cytokines generated by regulatory T cells (Tregs)

Breslin M, Pons L, Yue X, Kulis M, Jones SM, Vickery B, Burks AW. Peanut Oral Immunotherapy (OIT) confers long-term tolerance mediated by decreased T-helper Type 2 (TH2) cytokines and cytokines generated by regulatory T cells (Tregs). J Allergy Clin Immunol. 2010; AB20.


collapse authors with profiles